Join Nostr
2026-10-27 15:49:20 UTC
in reply to

jb on Nostr: Eager to keep impressing Wall Street with steroidal growth numbers and counting all ...

Eager to keep impressing Wall Street with steroidal growth numbers and counting all manner of nascent start-ups and emerging companies among its potential customers, Lucent apparently developed a habit over the years of goosing up its sales with so-called vendor-financing arrangements, in which Lucent would lend customers the money to buy equipment and sometimes install it too. Which all led in part to December’s $679 million “revenue recognition” mea culpa, in which Lucent essentially had to face the music for on-credit purchases that fell through.
When you said that I immediately thought of Lucent
https://time.com/archive/6931645/how-the-once-luminous-lucent-got-into-double-trouble/